Erik Deichmann Heegaard
Keine laufenden Positionen mehr
Vermögen: - $ am 31.05.2024
Karriereverlauf von Erik Deichmann Heegaard
Ehemalige bekannte Positionen von Erik Deichmann Heegaard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EVAXION BIOTECH A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 | 01.03.2023 |
| NOVO NORDISK A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | 01.01.2014 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.2015 | - |
Ausbildung von Erik Deichmann Heegaard
| University of Copenhagen | Doctorate Degree |
Statistik
International
| Dänemark | 4 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EVAXION BIOTECH A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Erik Deichmann Heegaard
- Erfahrung
